Downstream Versus Upstream Strategy for the Administration of P2Y12 Receptor Blockers
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 2520 participants.
Also called NCT02618837
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose diagnostic
- Phase
- Phase 4
- Enrolled
- 2,520 participants
- Sponsor
- Registry
-
NCT02618837
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Italy
- Registry status
- Unknown status
Technical summary
Registry record NCT02618837. Randomized; no masking; primary purpose diagnostic. Start 2015-12-14 (actual); primary completion 2021-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Downstream Versus Upstream Strategy for the Administration of P2Y12 Receptor Blockers
- Acronym
- DUBIUS
- Condition
- Unstable Angina or Non ST Elevated Myocardial Infarction
- Intervention (Procedure)
- Downstream strategy
- Intervention (Procedure)
- Upstream strategy
- Lead sponsor
- University of Padova
- Collaborator
- Azienda Ospedaliera di Padova
Record details
- Record id
cardio:ct-nct02618837- Content hash
bbd59e8609598a372627046668aa616d61fa2503aa8bc497b1d1399d7c72eebc